Clinical trial · Observational
Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukemia of T Cells.
Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Long non-coding RNAs (lncRNAs) are a class of biomarkers of crescent interest in the hematologic and oncologic field. They do not encode proteins and can alter gene expression by acting on different steps of regulation, including DNA methylation and chromatin structure. Recent data identified recurrent somatic alterations in genes involved in DNA methylation and post-translational histone modifications in T-ALL, suggesting that epigenetic homeostasis is critically required in restraining tumor development in the T-cell lineage. Further, recent studies showed that the expression levels of specific lncRNAs correlate with the prognosis of patients with Acute Lymphoblastic Leukemia of T-cells (T-ALL). The objectives of this research project are to identify T-ALL-specific lncRNAs to be used as new diagnostic and prognostic biomarkers of disease and to explore their role on chromatin reorganization and transcriptional regulation that may lead to the onset and progression of T-ALL.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Lymphoblastic Leukemia, Pediatric | Childhood Acute Lymphoblastic Leukemia | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| lncRNA signature analyses | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Childhood Acute Lymphoblastic Leukemia patients
- description
- Bone marrow mononuclear cells from childhood acute lymphoblastic leukemia of T cells
- interventionNames
- Diagnostic Test: lncRNA signature analyses
- label
- Healthy subjects
- description
- Cord blood mononuclear cells from healthy volounteers
- interventionNames
- Diagnostic Test: lncRNA signature analyses
Primary outcomes (1)
- measure
- Evaluation of the expression of selected lncRNAs in pediatric T-ALL patients and cellular models of T-ALL
- timeFrame
- 1-30 months
- description
- Study of the expression of selected lncRNAs in pediatric T-ALL patients by RT-PCR. Profiling of chromatin accessibility and DNA methylation landscape in pediatric T-ALL patients in comparison with the healthy subjects, through ATAC-seq and MethylC-seq experiments.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Year
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with a diagnosis of T-ALL 1-18 years aged of both sexes; * Presence of leukemic cells in peripheral blood of recruited patients. Exclusion Criteria: * Patients who refuse to participate in the study; * Patients not falling in the age group mentioned above
References
Publications (0)
Data not yet available